title: [Two new oral disease modifying therapies in relapsing remitting multiple sclerosis].
authors.affiliation: Service de neurologie, hôpital Pasteur, 30, avenue de la voie romaine, BP 69, 06002 Nice cedex 1, France. Electronic address: lebrun-frenay.c@chu-nice.fr.
authors.forename: C
authors.initials: C
authors.lastname: Lebrun
authors.affiliation: Service de neurologie, hôpital Hautepierre, avenue Molière, 67000 Strasbourg, France.
authors.forename: J
authors.initials: J
authors.lastname: de Seze
mesh_terms: D000284:Administration, Oral; D003437:Crotonates / Q000008:administration & dosage* / Q000009:adverse effects; D000069462:Dimethyl Fumarate; D005650:Fumarates / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D006885:Hydroxybutyrates; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy*; D009570:Nitriles; D035703:Therapies, Investigational; D014052:Toluidines / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D003437:Crotonates; D005650:Fumarates; D006885:Hydroxybutyrates; D009570:Nitriles; D014052:Toluidines; C527525:teriflunomide; D000069462:Dimethyl Fumarate